Development and Validation
of UV– Spectrophotometric Method of Tolterodine in
bulk and Pharmaceutical Dosage Form
B. Siddartha1*,
Dr. I. Sudheer Babu2, A. Krupalini1,
Prathyusha V.1
1Department of Pharmaceutical Analysis, Malla
Reddy College of Pharmacy, Secunderabad.
2Sir C.R. Reddy College of Pharmaceutical Sciences, Eluru.
*Corresponding Author E-mail: siddarthabethi@rediffmail.com
ABSTRACT:
A simple,
precise and accurate UV Spectrophotometric method has been developed for
estimation of Tolterodine in bulk and tablet dosage
form. In this method Tolterodine shows λmax at 280nm using 0.1N NaOH
as a solvent. The proposed method was validated as per ICH Q2 (R1) guidelines
for precision, linearity, accuracy and recovery. The responses were linear in
the range of 10-80μg/ml. The regression equation of the calibration graph
and correlation coefficient were found to be y = 0.006x - 0.003 and 0.999 respectively.
The recovery of the drug from the sample was ranged between 99.62% and 100.76%.
The %RSD values for both intraday and interday precision were less than 1%. The
limit of detection (LOD) and limit of quantification (LOQ) were found to be
0.715μg/ml and 2.167μg/ml respectively by simple UV spectroscopy.
KEYWORDS: Tolterodine, UV-Spectroscopy, Validation, NaOH, ICH guidelines.
INTRODUCTION:
Tolterodine,
is chemically 2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol.
Tolterodine is a potent and competitive muscarinic receptor antagonist used for the treatment of
urinary incontinence (incontinence in detrusor
instability) and other overactive bladder symptoms, such as urgency and high micturition frequency. The drug also increases functional
bladder volume. The drug blocks muscarinic receptors,
which can be found on the muscle cell of the bladder wall. Stimulation of these
receptors causes the bladder to contract and empty when these receptors are
blocked the muscle of the bladder wall contracts less. Tolterodine
acts on M1, M2, M3, M4 and M5 subtypes of muscarinic
receptors whereas modern anti muscarinic treatments
for overactive bladder only act on M3 receptors making them more selective[1]. Some analytical methods which include UV[2], visible spectrophotometric[3,4], HPLC[5-12] and
UPLC[13], have been reported in the literature for the determination of Tolterodine in biological fluids and in pharmaceutical
preparations. The developed method was validated as per ICH guidelines[14].
MATERIALS AND METHODS:
The
spectrophotometric measurements were carried out using a Shimadzu UV-1700
UV/Vis spectrophotometer with 1cm matched quartz cell and Shimadzu ELB 300
analytical balance, Tolterodine pure drug (99.95%)
was obtained as a gift sample from Dr. Reddy’s Laboratories Pvt
Ltd (Hyderabad, India). All chemicals and reagents used were of analytical
grade. Formulation used for studies was developed by Dr. Reddy’s Laboratories Pvt Ltd.
Preparation of Standard solution:
Standard drug of Tolterodine was
proposed by dissolving 10mg pure Tolterodine in 0.1N NaOH and transferred into 10ml volumetric flask to obtain
1000μg/ml of stock solution. The standard solution of Tolterodine
having concentration of 100μg/ml was scanned in UV range (200-400nm) in
1.0 cm cell against in solvent as blank and spectrum was obtained.
Determination of λmax:
100μg/ml of Tolterodine was prepared
and scanned in UV range of 200-400nm and spectrum was obtained. The λmax was found to be at 280nm wavelength where
absorbance was found maximum at this wavelength. Hence it is considered as
absorbance maxima (λmax).
Preparation of calibration curve:
Standard stock solution was suitably diluted with 0.1N NaOH to obtain concentrations ranging from
40-180μg/ml. Absorbance of these solutions was measured at 280nm.
Calibration curve was obtained by plotting graph between concentration and
absorbance.
Preparation of test solution:
20 Tablets were weighed and its average weight was determined. An
accurately weighed tablet powder equivalent to 10mg of Tolterodine
transferred into 100ml volumetric flask dissolved in 0.1N NaOH,
sonicated for 10min and volume was made up to the
mark. Solution was filtered using whattman filter
paper (No.41) to obtain 40μg/ml stock solution.
METHOD VALIDATION:
Linearity:
The absorbances were observed from 40 to
180μg/ml and were shown in Table-1. Linearity was obtained between 40 to
180μg/ml. Concentration graph was plotted for concentration and
absorbance. The equation of calibration curve obtained was y = 0.006x –
0.003. The correlation coefficient (r)
was found to be 0.999.
Table 1: Calibration data for analysis of Tolterodine in 0.1N NaOH at λmax = 280nm
S.No. |
Concentration (µg/ml) |
Mean
Absorbance (+ SD)* |
1 |
40 |
0.242 (+ 0.0006) |
2 |
60 |
0.363 (+ 0.001) |
3 |
80 |
0.479 (+ 0.0015) |
4 |
100 |
0.593 (+ 0.0012) |
5 |
120 |
0.719 (+ 0.0015) |
6 |
140 |
0.846 (+ 0.0021) |
7 |
160 |
0.967 (+ 0.0015) |
8 |
180 |
1.088 (+ 0.0012) |
*n=3 (Average of 3 determinations)
Accuracy:
To determine the accuracy of the method recovery was performed by
standard addition method. To pre-analyzed sample known amount of standard Tolterodine was spiked in different concentrations. The
recovery was performed at three levels 80%, 100% and 120% of standard Tolterodine. The solutions were prepared in triplicate and
the accuracy was indicated by %
Recovery.
Precision:
Intraday and Interday Precision:
The concentration of 80μg/ml, 100μg/ml and 120μg/ml
of Tolterodine (on label claim basis) was taken. The
absorbance of the final solution was read after 0hr, 12hr and 24hr in 1.0 cm
cell at selected wavelength. Similarly the absorbance of the same solutions was
read on 1st, 2nd and 3rd day. All the
solutions are prepared triplicate and analyzed.
Ruggedness:
It was carried out by analyzing the sample by two analysts and
estimation of drug by proposed methods. The % RSD was calculated.
RESULTS AND DISCUSSIONS:
Attempt has been made to develop rapid, sensitive, economic,
precise and accurate analytical method for Tolterodine
in pure and pharmaceutical dosage form. The proposed method is based on UV
Spectrophotometric absorption in UV region using 0.1N NaOH
as solvent. Maximum absorbance was found to be at 280nm and is shown in Figure: 1. Beer’s law was obeyed in
concentrations ranging from 40 to 180μg/ml is incorporated in Table: 1. The correlation coefficient
values were above 0.999 which shows that absorbance was linear with
concentration (Figure: 2). The
%Recovery studies were performed at 80%, 100% and 120% and was represented in Table: 2. The assay of the two brands
were performed and the results incorporated in Table: 3. LOD and LOQ were found to be 0.715μg/ml and
2.167μg/ml (Table: 4).
Precision of the method was confirmed by Intraday and Interday analysis, %RSD
values were represented in Table: 5 and
6. The ruggedness parameter was performed between two analysts and %RSD was
found 0.27 and 0.09 (Table: 7). The
optical characteristics such as Beer’s law limit, correlation coefficient,
slope, intercept, molar absorptivity, scandell’s sensitivity were calculated and validated (Table: 8). The method was validated
and found to be simple, sensitive, accurate and precise. Hence the proposed
method could be effectively adopted for routine quality control of Tolterodine in bulk and formulated tablet dosage form.
Fig - 1: UV Spectrum of Tolterodine in 0.1N NaOH at λmax = 280nm
Table-2: Recovery data of Tolterodine in 0.1N NaOH
Ingredient |
Amount of drug from
formulation |
Amount of standard added |
Percentage added |
Amount added (µg/ml) |
Amount found (µg/ml) |
% Recovery (Mean + RSD)* |
Tolterodine |
100µg |
80µg |
80% |
79.60 |
80.28 |
100.85 + 0.21 |
Tolterodine |
100µg |
100µg |
100% |
99.49 |
99.39 |
99.89 + 0.10 |
Tolterodine |
100µg |
120µg |
120% |
119.38 |
119.81 |
100.35 + 0.36 |
*n=3 (Average of 3 determinations)
Fig - 2: Calibration curve of Tolterodine in 0.1N NaOH showing
linearity relationship
Table-3:
Results of analysis of laboratory samples (Assay)
Sample |
Label |
Amount found |
% Purity + RSD* |
Brand-1 Tolterodine |
4mg |
4.01mg |
99.79 +
0.77 |
Brand-2 Tolterodine |
4mg |
4.02mg |
99.90 +
0.59 |
*n=3 (Average of 3 determinations)
Table-4:
Lowest Limit of detection and Lowest Limit of quantification
LOD (µg/ml) |
LOQ (µg/ml) |
0.715 |
2.167 |
Table-5: Results of Intraday Precision of Tolterodine in 0.1N NaOH
Parameter |
% Recovery Estimated (Mean + RSD)* |
||
80 (µg/ml) |
100 (µg/ml) |
120 (µg/ml) |
|
At 0 hr |
99.26 +
0.12 |
99.09 +
0.17 |
99.41 +
0.12 |
At 12 hr |
99.33 +
0.10 |
99.29 +
0.24 |
99.23 +
0.07 |
At 24 hr |
99.39 +
0.22 |
99.24 +
0.15 |
99.47 +
0.07 |
*n=3 (Average of 3
determinations)
Table-6: Results of Inter-day
Precision of Tolterodine in 0.1N NaOH
Parameter |
% Recovery Estimated (Mean +
RSD)* |
||
80 (µg/ml) |
100 (µg/ml) |
120 (µg/ml) |
|
Day-1 |
99.46 +
0.12 |
99.18 +
0.34 |
99.37 +
0.19 |
Day-2 |
99.73 +
0.22 |
99.29 +
0.08 |
99.51 +
0.08 |
Day-3 |
99.48 +
0.23 |
99.13 +
0.24 |
99.32 + 0.23 |
*n=3 (Average of 3 determinations)
Table-7: Results of
Ruggedness of Tolterodine in 0.1N NaOH
Ruggedness |
% Purity + RSD* |
Analyst – 1 |
100.07 +
0.27 |
Analyst – 2 |
99.97 + 0.09 |
*n=3 (Average of 3 determinations)
Table-8: Validation
Parameters
Parameters |
Results |
Absorption
maxima λmax (nm) |
280 |
Beer’s law limit
(µg/ml) |
40-180 |
Molar Absorptivity (L mole-1, cms-1) |
1.9302 x 103 |
Sandell’s
sensitivity (µg/cm2/0.001) |
0.1686 |
Correlation
coefficient |
0.999 |
Regression
equation |
y = 0.006x -
0.003 |
Limit of
detection |
0.715 |
Limit of
quantification |
2.167 |
Precision(% RSD) |
0.22 |
CONCLUSION:
The spectrophotometric method being reported for the assay of Tolterodine in pure form and also in its formulations is
simple and inexpensive. The proposed method was found to be simple, sensitive,
accurate and with good precision. Thus, this approach could be considered for
the analysis of this drug in the quality control laboratories.
ACKNOWLEDGEMENTS:
The authors are thankful to Dr. Reddy’s Laboratories Pvt. Ltd. for
providing standard drug samples and also to Malla
Reddy College of Pharmacy, for providing the facilities to carry out the work.
REFERENCES:
1. |
http://en.wikipedia.org/wiki/Tolterodine |
2. |
Shetty
SK, Shah A. International Journal of
Pharmaceutical Sciences and Research, 2011: 2(6); pp 1456-1458. |
3. |
Mohammed Ishaq B, Vanitha Prakash K, Manjula B, Hari kumar C, Usha Rani G. International Journal of Chemical and
Analytical Science., 2010: 1(7); pp 165-167. |
4. |
Walash
MI, Belal F, EI -Enany N
and Elmansi E. International Journal of Pharmaceuti cal
Sciences and Research., 2011: 2(11); pp 2849-2855. |
5. |
Vinay S,
Zahid Z, Mazhar F. Indian J. chem. Technol., 2006: 13(3); pp 242-246. |
6. |
Krishna SR, Rao BM, Rao NS. Rasayan J. Chem., 2009: 2(1); pp 144-150. |
7. |
Dwibhashyam VS, Keerthi P, Ratna
JV, Nagappa AN. PDA J. Pharm. Sci. Technol., 2009: 63(3); pp 234-239. |
8. |
Xia ZL, Chen
ZY, Yao TW. Pharmazie 2007: 62; pp 170-173. |
9. |
Kumar YR, Ramulu G, Vevakanand VV, Vaidyanathan G, Srinivas K,
Kumar MK, Mukkanti K. J. Pharm. Biomed. Anal., 2004: 35; pp 1279-1285. |
10. |
Madhavi
A, Reddy GS, Suryanarayana MV, Naidu A. Development
and validation of a new analytical method for the determination of related
components in tolterodine tartrate
using LC. Chromatographia., 2008:
68; 399-407. |
11. |
Sinha
VR, Jindal V, Kumar RV, Bhinge
JR, Goel H. Acta Chromatogr., 2011: 23; pp 133-143. |
12. |
Shetty
SK, Shah A. Int. J. Pharm. Tech.
Res., 2011: 3; pp 1083-1087. |
13. |
Ramesh
Y, Chandra Sekhar V, Umamaheshwar
P, Balaram P, Murthy YLN, Atchuta
Ramaiah P. Scientia Pharmaceutica
2012: 80; pp 101-114. |
14. |
ICH, Q2(R1),
Harmonized Tripartite Guideline, Validation of Analytical procedures Text and
methodology, International
conference on Harmoni zation(ICH),
Geneva, Nov. 2005. |
Received on 07.08.2013 Accepted on 05.09.2013
© Asian Pharma
Press All Right Reserved
Asian
J. Pharm. Ana. 3(3):
July-Sept. 2013; Page 102-104